1. 1. DeVore GR. The importance of the cerebroplacental ratio in the evaluation of fetal well-being in SGA and AGA fetuses. Am J Obstet Gynecol 2015; 213: 5-15.
2. 2. Flood K, Unterscheider J, Daly S, Geary MP, Kennelly MM, McAuliffe FM, et al. The role of brain sparing in the prediction of adverse outcomes in intrauterine growth restriction: Results of the multicenter PORTO study. Am J Obstet Gynecol 2014; 211: 288. e1-e5.
3. 3. Khalil AA, Morales-Rosello J, Morlando M, Hannan H, Bhide A, Papageorghiou A, et al. Is fetal cerebroplacental ratio an independent predictor of intrapartum fetal compromise and neonatal unit admission? Am J Obstet Gynecol 2015; 213: 54. e1-e10.
4. 4. Akolekar R, Syngelaki A, Gallo DM, Poon LC, Nicolaides KH. Umbilical and fetal middle cerebral artery Doppler at 35-37 weeks' gestation in the prediction of adverse perinatal outcome. Ultrasound Obstet Gynecol 2015; 46: 82-92.
5. 5. Ropacka-Lesiak M, Korbelak T, Świder-Musielak J, Breborowicz G. Cerebroplacental ratio in prediction of adverse perinatal outcome and fetal heart rate disturbances in uncomplicated pregnancy at 40 weeks and beyond. Arch Med Sci 2015; 11: 142.
6. 6. Karlsen HO, Ebbing C, Rasmussen S, Kiserud T, Johnsen SL. Use of conditional centiles of middle cerebral artery pulsatility index and cerebroplacental ratio in the prediction of adverse perinatal outcomes. Acta Obstet Gynecol Scand 2016; 95: 690-696.
7. 7. Morales‐Roselló J, Khalil A, Morlando M, Bhide A, Papageorghiou A, Thilaganathan B. Poor neonatal acid-base status in term fetuses with low cerebroplacental ratio. Ultrasound Obstet Gynecol 2015; 45: 156-161.
8. 8. Nicolaides K, Economides D, Soothill P. Blood gases, pH, and lactate in appropriate-and small-for-gestational-age fetuses. Am J Obstet Gynecol 1989; 161: 996-1001.
9. 9. Morales‐Roselló J, Khalil A, Morlando M, Papageorghiou A, Bhide A, Thilaganathan B. Changes in fetal Doppler indices as a marker of failure to reach growth potential at term. Ultrasound Obstet Gynecol 2014; 43: 303-310.
10. 10. D'antonio F, Patel D, Chandrasekharan N, Thilaganathan B, Bhide A. Role of cerebroplacental ratio for fetal assessment in prolonged pregnancy. Ultrasound Obstet Gynecol 2013; 42: 196-200.
11. 11. Monteith C, Flood K, Mullers S, Unterscheider J, Breathnach F, Daly S, et al. Evaluation of normalization of cerebro-placental ratio as a potential predictor for adverse outcome in SGA fetuses. Am J Obstet Gynecol 2017; 216: 285. e1-e6.
12. 12. Flatley C, Greer R, Kumar S. Magnitude of change in fetal cerebroplacental ratio in third trimester and risk of adverse pregnancy outcome. Ultrasound Obstet Gynecol 2017; 50: 514-519.
13. 13. Morales-Roselló J, Khalil A, Alberola-Rubio J, Hervas-Marín D, Morlando M, Bhide A, et al. Neonatal acid-base status in term fetuses: mathematical models investigating cerebroplacental ratio and birth weight. Fetal Diagnos Ther 2015; 38: 55-60.
14. 14. Regan J, Masters H, Warshak CR. Estimation of the growth rate in fetuses with an abnormal cerebroplacental ratio compared to those with suspected growth restriction without evidence of centralization of blood flow. J Ultrasound Med 2015; 34: 837-842.
15. 15. Khalil A, Morales‐Roselló J, Townsend R, Morlando M, Papageorghiou A, Bhide A, et al. Value of third‐trimester cerebroplacental ratio and uterine artery Doppler indices as predictors of stillbirth and perinatal loss. Ultrasound Obstet Gynecol 2016; 47: 74-80.
16. 16. Murata S, Nakata M, Sumie M, Sugino N. The Doppler cerebroplacental ratio predicts risk of non‐reassuring fetal status for fetal growth restriction in term pregnancy. Ultrasound Obstet Gynecol 2009; 34: 56.
17. 17. Prior T, Paramasivam G, Bennett P, Kumar S. Are fetuses that fail to achieve their growth potential at increased risk of intrapartum compromise? Ultrasound Obstet Gynecol 2015; 46: 460-464.
18. 18. Khalil A, Morales-Rosello J, Khan N, Nath M, Agarwal P, Bhide A, et al. Is cerebroplacental ratio a marker of impaired fetal growth velocity and adverse pregnancy outcome? Am J Obstet Gynecol 2017; 216: 606. e1-10.